Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

(2009) · PubMed Central · Cited by 44,859

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890

J. Submicrosc. Cytol. Pathol.

Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,182

Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., CARUCCI, P., Musso, A., Paolis, P. D., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,436

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,304

Lipid Metabolism in Liver Cancer

Lu, G., & Hooi, S. C. (2017) · InTech eBooks · doi:10.5772/64993 · Cited by 4

Metabolic Risk Factors in Hepatocellular Carcinoma

Suceveanu, A., Mazilu, L., Gheorghe, A. D., Stoian, A. P., Voinea, F., & Suceveanu, A. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.80527 · Cited by 3

Epidemiology of hepatocellular carcinoma in nonalcoholic fatty liver disease

Moriguchi, M., Seko, Y., Takahashi, A., & Itoh, Y. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2019.20 · Cited by 4

NAFLD/NASH-Related Hepatocellular Carcinoma: Along with the Role of Genetics

Fujioka, K. (2020) · Open Access Journal of Cancer & Oncology · doi:10.23880/oajco-16000165 · Cited by 2

Treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)

Bril, F., Ntim, K., Lomonaco, R., & Cusi, K. J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch20 · Cited by 3

Bariatric Surgery for the Treatment of Nonalcoholic Fatty Liver Disease: Is Vertical Sleeve Gastrectomy the Best Future Option?

HSUEH, W. H., Shope, T. R., Koch, T. R., & Smith, C. I. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.564 · Cited by 3

Evaluation of abnormal liver biochemical test results: Does the hare finally beat the tortoise?

Poterucha, J. J., & Friedman, L. S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.019 · Cited by 3

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma

Yang, L., Li, P., Zhao, J., Bai, Z., Zeng, G., Liu, X., Zou, B., & Li, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02051-y · Cited by 2

Investigation of liver diseases using liver Doppler ultrasound in patients with inflammatory bowel diseases

Shintaku, D., Lopes, M. A., Beraldo, R. F., de Oliveira, E. C. S., Herrerias, G. S. P., de Oliveira, A. C. B., Baima, J. P., Barbosa, W. F., Silva, G. F., & Sassaki, L. Y. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2025e14523 · Cited by 2

Concurrent Steatotic Liver Disease and Prognosis After Curative Resection of Hepatocellular Carcinoma

Liu, Y.-W., Wang, C., Liu, Y., Li, W.-F., Yen, Y., Kuo, Y., Wang, H.-M., & Tsai, M. (2026) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s577506 · Cited by 2

Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy

Cai, B., Lv, D., Qiu, Q., 熊文举, Tang, H., Bai, Y., Zhou, S., Hu, Y., Safadi, R., Wang, C., et al. (2026) · Cancers · doi:10.3390/cancers18142224 · Cited by 2

Is That Possible to Stop or Cease the NASH to Turn into HCC?

Uygun, A. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9961-6 · Cited by 3

Hepatocellular carcinoma disguised as liver abscesses

Gowarty, J., Ghauri, A., Martinez, G., & Birdwell, A. L. (2018) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2018.1444252 · Cited by 2

Prevalencia y características clínicas de la esteatohepatitis no alcohólica en una población con hipertensión arterial esencial

Carretero, R. G., Barquero‐Pérez, Ó., Mora-Jiménez, I., Soguero-Ruíz, C., Goya–Esteban, R., Rodríguez-Castro, C., & Ramos, J. (2019) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2018.10.001 · Cited by 3

Resumen ejecutivo: Enfermedad por hígado graso no alcohólico en sujetos con diabetes mellitus tipo 2: Postura conjunta de la Asociación Chilena de Hepatología (ACHHEP) y la Sociedad Chilena de Diabetología (SOCHIDIAB)

Arab, J. P., Castro, L., GOMEZ, P. C., Vignolo, P., Arrese, M. A., Francisco Barrera, M., Castro, F., Díaz, L. A., Donoso, A., Elgueta, K., et al. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000901360 · Cited by 2

Hepatocellular Carcinoma from a Hepatologist's Perspective

Roldan, G. A., Blomker, J., & Aby, E. S. (2023) · Seminars in Interventional Radiology · doi:10.1055/s-0043-1777846 · Cited by 2

Association between insulin glargine and risk of cancer: an updated and comprehensive systematic review and meta-analysis of observational studies

Zooravar, D., Chehrehgosha, H., & Soltani, P. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01412-7 · Cited by 2

Yi Mai Granule Improves High‐Fat Diet–Induced Nonalcoholic Fatty Liver Disease in Mice by Regulating Gut Microbiota and Metabolites

Pang, L., Liu, Y., Yuan, C., Ju, Y., Wu, J., Cheng, M., Jin, S., Fan, Y., Zhang, H., Wang, Y., et al. (2025) · International Journal of Microbiology · doi:10.1155/ijm/2273986 · Cited by 2

Discovery and Validation of Non-canonical Antigens for Hepatocellular Carcinoma Immunotherapy

Li, S., Dong, Y., Liu, J., Li, S., Pu, D., Guo, Y., Wong, C. K., Wong, N., & Wong, J. W. H. (2026) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzag082 · Cited by 2

Introductory Chapter: Etiology and Pathogenesis of Hepatocellular Carcinoma

Streba, C. T., Vere, C. C., Rogoveanu, I., & Florescu, N. D. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78328 · Cited by 2

Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes

Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_164 · Cited by 2

Pharmacological agents for nonalcoholic steatohepatitis

Guillaume, M., & Ratziu, V. (2013) · Hepatology International · doi:10.1007/s12072-013-9482-8 · Cited by 2

Características clínicas y descompensación en pacientes con cirrosis hepática atendidos en dos centros de hepatología en la ciudad de Bogotá D.C., 2010-2014 Clinical Characteristics and Decompensation in Patients with Liver Cirrhosis Treated at Two Hepatology Centers in Bogota DC from 2010 To 2014

Prieto, E. O. J., Prieto, R. G., Rojas, E., González, L., & Mendivelso, F. (2016) · Cited by 2

Clinical Aspects of Nonalcoholic Fatty Liver Disease

Mashav, N., & Shibolet, O. (2014) · Oxidative stress and disease · doi:10.1201/b17315-3 · Cited by 2

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Jang, B. K. (2016) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0104 · Cited by 2

Worse Outcomes among African Americans with Liver Cancer: What Might Cause the Disparity?

Ad, B. (2017) · Austin Journal of Gastroenterology · doi:10.26420/austinjgastroenterol.2017.1079 · Cited by 2

Irreversible Electroporation of Liver Tumors

Nielsen, K., Scheffer, H. J., van den Tol, M. P., & Nilsson, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-55113-5_10 · Cited by 2

Trends of etiology and treatment in hepatocellular carcinoma over the years

Vatansever, S., & Paköz, Z. B. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20184681 · Cited by 1

The Asian Grocery Store-Based Cancer Education Program: Creating New Education Modules

Truong, L., Tat, J., Booy, M., Le, A. V., Marasigan, J. M., Yuan, C. W.-Y., Zeng, A., Panchal, A., & Sadler, G. R. (2015) · Journal of Cancer Education · doi:10.1007/s13187-015-0836-x · Cited by 2

Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma

Best, J., Sydor, S., Bechmann, L. P., & Canbay, A. E. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.56 · Cited by 2

ASSOCIATION OF NON ALCOHOLIC FATTY LIVER WITH TYPE 2 DIABETES MELLITUS

MOHAMMED, M. H., ALDUHOKY, L. S., SARHAN, S. A., & Ahmed, I. H. (2021) · Duhok Medical Journal · doi:10.31386/dmj.2021.15.1.2 · Cited by 2

Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysis

Gurusamy, K. S., Tsochatzis, E. A., & Madden, A. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013157 · Cited by 3

Chronic hepatitis and other liver disease

Damme, P. V., Lernout, T., Herck, K. V., Marinho, R. T., Paraná, R., & Shouval, D. (2015) · doi:10.1093/med/9780199661756.003.0216 · Cited by 2

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series

Alencar, R. S. D. S. M., Oliveira, C., Chagas, A., da Fonseca, L. D., Maccali, C., Saud, L. R. D. C., Xerfan, M., Stefano, J., Herman, P., D'Albuquerque, L. A., et al. (2022) · Clinics · doi:10.1016/j.clinsp.2022.100097 · Cited by 3

Non‐Alcoholic Fatty Liver Disease

Hardy, T., & Day, C. P. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch28 · Cited by 2

Non-alcoholic Fatty Liver Disease

Kim, S. F., & Choi, J. H. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_36-2 · Cited by 1

An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules

Xiao, Z., Yang, F., Liu, Z., Chen, X., Ma, S., & Li, H. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241293019 · Cited by 1

Reducing complications of metabolic dysfunction–associated steatotic liver disease

Wada, N., Iwaki, M., Kobayashi, T., Nakajima, A., & Yoneda, M. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2502549 · Cited by 1

The Association Between Physical Activity, Sedentary Time, and Sleep with Risk of Hepatocellular Carcinoma in Patients with Cirrhosis

Ma, S., Alsabawi, Y., Kanwal, F., Duong, H. T., El-Serag, L., Singal, A. G., Rich, N. E., Khaderi, S. A., Asrani, S. K., El‐Serag, H. B., et al. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09527-5 · Cited by 1

Complement factor D is a drug target for metabolic-associated fatty liver disease

Guo, R., Li, Z., Wu, J., Zhang, Z., Shu, J., Zhou, X., Zhou, W., Chen, Y., Guan, D., Wang, Q., et al. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.11.006 · Cited by 1

Research advances in self-assembled peptide delivery systems for fibrosis treatment

Zhang, Y., Su, D., & Wang, Y. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100043 · Cited by 1

DDR2 ameliorates nonalcoholic hepatic steatosis by activating the AMPK/ACC pathway

Guo, M., Lin, L., Wang, Y., Gao, J., Xiang, W., Hua, H., Wang, D., Huang, C., Wang, X., Zou, B., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-42992-0 · Cited by 1

Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease

PLAKIDA, A. L., Юшковська, О., & Sierpińska, L. E. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i3.113284 · Cited by 1

Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common?

Mittal, S., White, D. L., Kanwal, F., Sussman, N., & El‐Serag, H. B. (2015) · Current Hepatology Reports · doi:10.1007/s11901-015-0259-5 · Cited by 1

Non-Alcoholic Fatty Liver Disease

Alhadyan, R. H. M., Khojah, A. A. Y., & Alanazi, A. G. A. (2018) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0043808 · Cited by 1

Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?

Campana, B., Semela, D., Heim, M. H., & Bernsmeier, C. (2015) · EMJ Hepatology · doi:10.33590/emjhepatol/10314903 · Cited by 1

Pediatric Obesity and the Liver

Hardee, S., & Morotti, R. A. (2013) · Academic Forensic Pathology · doi:10.23907/2013.005 · Cited by 1

Hepatocellular Carcinoma: Epidemiology, Basic Principles of Treatment, and Clinical Data

Singal, A. G., Gopal, P., & Yopp, A. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-54531-8_13 · Cited by 1

How Can Fatty Liver Lead to Liver Cancer and How Can We Simply Assess It?

Toman, D., Vavra, P., Jelínek, P., Ostruszka, P., Ihnat, P. M., Foltys, A., & Roman, J. H. (2019) · Acta Scientific Gastrointestinal Disorders · doi:10.31080/asgis.2019.02.0100

The molecular mechanism on the association of diabetes mellitus with hepatocellular carcinoma

Zheng, W., Deng, M., & Gong, J. (2020) · International Surgery Journal · doi:10.18203/2349-2902.isj20205921 · Cited by 1

A Review of Non-Alcoholic Fatty Liver Disease: From Obesity to Liver Transplant

Anyane‐Yeboa, A., & Stewart, C. A. (2015) · Canadian Journal of General Internal Medicine · doi:10.19144/1911-1606.10.3.4 · Cited by 1

Liver Cancer - Genesis, Progression and Metastasis

Feitelson, M. A., & Arzumanyan, A. L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100845 · Cited by 1

Hepatozelluläres Karzinom – Screening und Surveillance

Köpping-Segerling, C. C., Pohl, M., Canbay, A. E., & Best, J. (2022) · Die Gastroenterologie · doi:10.1007/s11377-022-00651-6 · Cited by 1

Establishment of Reference Interval for M2BPGI Glyco-Biomarker in the Serum of Mongolian People

Enkhbayar, U., Khuyagaa, S.-O., Dambadarjaa, D., Namdag, B., & Radnaa, O. (2020) · Central Asian Journal of Medical Sciences · doi:10.24079/cajms.2020.12.004 · Cited by 1

Prospects of evolution-based artificial intelligence models in genome-wide studies to stratify genetic risk variants in nonalcoholic fatty liver disease

Huang, H. Y. R., Awuah, W. A., Garg, T., Ng, J. C., Mehta, A., Ramamoorthy, K., Kalmanovich, J. B., & Hasan, M. M. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000743 · Cited by 2

Disrupting Poly(ADP-ribosyl)ating Pathway Creates Premalignant Conditions in Mammalian Liver

Karpova, Y. D., Orlicky, D. J., Schmidt, E. E., & Tulin, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417205 · Cited by 1

Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

Lu, M., Wei, Y., Wang, C., Liang, P., Yeh, M., Tsai, Y.-S., Tsai, P., Ko, Y., Lin, C., Chen, K., et al. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i10.103716 · Cited by 1

Multiparametric ultrasound evaluation of metabolic dysfunction-associated fatty liver disease in minipigs

Chabouh, G., Pradier, B., Denis, L., Baida, R., Hingot, V., Chavignon, A., Bodard, S., Lesage, L., Helbert, A., Brzustowski, A., et al. (2025) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2025.06.011 · Cited by 1

Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes

Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_164-1 · Cited by 1

Atypical Progress of Primary Undiagnosed Hepatoblastoma

Romaniuk, A. M., Piddubnyi, A., & Sikora, V. (2016) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v15i2.25983 · Cited by 1

A short review on early HCC: MRI findings and pathological diagnosis

Raveendran, S., & Lu, Z. (2017) · Radiology of Infectious Diseases · doi:10.1016/j.jrid.2017.08.008 · Cited by 1

Management of Primary Hepatic Carcinoma by Traditional Chinese Medicine

Jinlai, C., Jing, L., & Meng, X. (2018) · Herbal Medicine Open Access · doi:10.21767/2472-0151.100036 · Cited by 1

Nonalcoholic Fatty Liver

Kudaravalli, P., & John, S. (2019) · StatPearls · Cited by 1

Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development

Vakhrushev, Y. M., Сучкова, Е. В., & Павловна, Л. А. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.12.000134 · Cited by 1

Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma

Jia, Y., Shu, M., Li, X., Yu, H., Chen, S., & Xie, S. (2020) · Evolutionary Bioinformatics · doi:10.1177/1176934320951571 · Cited by 1

Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study

Kim, M. N., Han, K., Yoo, J., Ha, Y., Chon, Y. E., Lee, J. H., & Hwang, S. G. (2021) · International Journal of Cancer · doi:10.1002/ijc.33920 · Cited by 1

Signature of Visfatin mRNA Expression and its Serum Level in Correlation with susceptibility and progression of Non-Alcoholic Fatty Liver Disease among Obese Patients

Rashad, N. M., Khalil, O. A., Sharafeddin, M., Hussien, M., Ibrahim, M., & Sherif, M. (2022) · Zagazig University Medical Journal · doi:10.21608/zumj.2022.114058.2450 · Cited by 1

Tumors of the Liver

Niazi, M. A., Shukla, P. A., & Pyrsopoulos, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_51 · Cited by 1

Hepatozelluläres Karzinom bei nicht-alkoholischer Steatohepatitis

Best, J., & Canbay, A. E. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_23 · Cited by 1

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients

Truong, E., & Noureddin, M. (2022) · Hepatoma Research · doi:10.20517/2394-5079.2022.63 · Cited by 1

Burnout and Lived Experiences among Caregivers of Chronic Liver Disease Patients

Bindhu, G. D. P. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23628110920 · Cited by 1

The contribution of vascular adhesion protein-1 to glucose and lipid homeostasis in the liver

Karim, S. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1

Genomic studies in non-alcoholic fatty liver disease

Liu, Y. (2017) · Cited by 1

The global research of artificial intelligence on metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (Preprint)Preprint

Huang, Y., Zhu, M., Wang, Z., Cao, J., & Xiong, Z. (2023) · doi:10.2196/preprints.46914 · Cited by 1

Loss of cis-PTase function in the liver promotes a highly penetrant form of fatty liver disease that rapidly transitions to hepatocellular carcinomaPreprint

Singh, A. K., Chaube, B., Citrin, K., Fowler, J. W., Lee, S., Catarino, J., Knight, J., Lowery, S. C., Shree, S., Boutagy, N., et al. (2023) · bioRxiv · doi:10.1101/2023.11.13.566870 · Cited by 1

HCC‐Früherkennung bei Patienten mit chronischen Lebererkrankungen

Waidmann, O., Welzel, T. M., & Trojan, J. (2014) · Die Gastroenterologie · doi:10.1007/s11377-014-0940-1

COMBATING β-CATENIN DRIVEN HEPATOCELLULAR CARCINOMA

Delgado, E. R. (2014) · D-Scholarship@Pitt (University of Pittsburgh)

Análise da expressão de EGFR e de proteínas relacionadas em carcinoma hepatocelular, tecido hepático circunjacente e metástase: estudo clínico-patológico em autópsias

da Silva, A. S. F. (2013) · doi:10.11606/t.5.2013.tde-01082013-133352

Hepatobiliary Quiz–12 (2014)

Agrawal, S., & Dhiman, R. K. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.11.004

Hepatology Articles in CGH: 2013 in Review

Fallon, M. B. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.001

VEGFA gene locus (6p12) amplification and colorectal cancer: implications for patients' response to therapy

der Würde, E. (2014)

Hepatic and Extrahepatic Malignancies in NAFLD

Nascimbeni, F., & Ratziu, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_14

Cancer of the liver, biliary tract and pancreas

Tobias, J. S., & Hochhauser, D. (2014) · doi:10.1002/9781118468753.ch15

Screening for NAFLD in high‐risk populations

Lessan, N. G. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch18

Diagnosis of Hepatobiliary Malignancies

Xu, S., Guo, X., Shaffer, V. O., Hao, J., & Cai, Q. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814618991_0017

VIII. The Prognosis and Follow-up

Tateishi, R., & Koike, K. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.62

Obergurgl Research Conference Abstracts on "Cancer Stem Cells: Impact on Treatment"

Skvortsova, I. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.58

Regulation of Metabolism by Hepatic OXPHOS: A Dissertation

Akie, T. E. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2388v

Malignant Liver Lesions

Loudin, M. G., Mascarenhas, R. C. V., & Schlansky, B. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_6

NAFLD-Related HCC: How Should the Shift in Epidemiology Change Our Prevention and Surveillance Strategies?

Tau, J., Thrift, A., & Kanwal, F. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0329-y

Intestinal Microbiota, Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: The Potential Role of Dysbiosis in the Hepatocarcinogenesis

Brandi, G., Lorenzo, S. D., Candela, M., & Tovoli, F. (2017) · InTech eBooks · doi:10.5772/67322

Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis

Koppe, S., & Arshad, H. M. S. (2017) · Digestive Disease Interventions · doi:10.1055/s-0037-1603572

Weight Reduction Improves Adipokines Profile and Glucose Control of Patients with Nonalcoholic Fatty Liver Disease

El-Kader, S. M. A. (2017) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2017.03.555608

Mitigating the scourge of non-alcoholic fatty liver disease in Ghana

Agyei-Nkansah, A. A. (2017) · Ghana Medical Journal · doi:10.4314/gmj.v51i3.1

Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes

Cusi, K. J. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_4

Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis

Zhi-fang, W. (2017) · International Journal of Immunotherapy and Cancer Research · doi:10.17352/2455-8591.000017

Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma…

Oh, H., & Jun, D. W. (2017) · Journal of Liver Cancer · doi:10.17998/jlc.17.2.117

Pathomorphological analysis of nonalcohoholic and alcoholic steathohepatitis adverse consequences

Tumansky, V. A., Фень, С. В., & Tumanskaya, L. M. (2017) · Morphologia · doi:10.26641/1997-9665.2017.4.59-74

A study on fatty liver in patients admitted to medical wards in tertiary hospital

Shaik, K., Deepthi, K., Nagabhushana, M. V., & Keerthana, B. (2018) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20184241

Neoplasia in Patients with Excess Fat Mass

Hurley, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_17

Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression

Orci, L. A., Sanduzzi-Zamparelli, M., Caballol, B., Sapena, V., Colucci, N., Torres, F., Bruix, J., Reig, M., & Toso, C. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.002 · Cited by 218

Incidence of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: A meta-analysis and meta-regression

Orci, L. A., Caballol, B., Sanduzzi‐Zamparelli, M., Sapena, V., Colucci, N., Torres, F., Bruix, J., Reig, M., & Toso, C. (2021) · British journal of surgery · doi:10.1093/bjs/znab202.022 · Cited by 2

Nonalcoholic fatty liver disease and hepatocellular carcinoma: Distinct links

Hsu, S.-J., & Huang, H.-C. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000571 · Cited by 2

Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease

Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795

Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective

Farrell, A., Ryan, M. C., & Howell, J. A. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2019.019 · Cited by 9